Global Cord Blood (NYSE:CO) is scheduled to post its quarterly earnings results after the market closes on Thursday, August 23rd.
Global Cord Blood (NYSE:CO) last released its quarterly earnings data on Tuesday, June 26th. The medical research company reported $0.04 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.13 by ($0.09). Global Cord Blood had a net margin of 25.12% and a return on equity of 7.79%. The company had revenue of $37.14 million for the quarter.
Shares of NYSE:CO traded down $0.04 during midday trading on Friday, reaching $7.25. 9,432 shares of the company traded hands, compared to its average volume of 218,073. Global Cord Blood has a 12 month low of $7.14 and a 12 month high of $14.95. The firm has a market cap of $892.47 million, a price-to-earnings ratio of 23.87 and a beta of 0.49.
The business also recently disclosed an annual dividend, which will be paid on Monday, August 20th. Investors of record on Monday, July 30th will be paid a dividend of $0.08 per share. The ex-dividend date of this dividend is Friday, July 27th. This represents a dividend yield of 0.93%.
Global Cord Blood Company Profile
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services.
Further Reading: Google Finance Portfolio Tips and Tricks
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.